Click on any study to read more about what the research is for, who we need to take part, what may be involved and who to contact for more information.
- Impact of daily behaviour on weight-loss drug effectiveness
-
This study aims to understand how day-to-day behaviours such as meal timing, physical activity, sleep, and medication use, affect short-term changes in blood glucose levels in people who are using Mounjaro® (tirzepatide) or Ozempic® (semaglutide).
While these medications are effective in supporting blood glucose control and weight management, there is limited evidence on how daily behaviours may influence their effectiveness in real-world settings.
We will collect information on food intake, medication timing, sleep, physical activity, and blood glucose levels over a 7-day period in everyday (free-living) settings.
The findings from this study may offer preliminary insights into how lifestyle behaviours influence medication response and could help inform future research and the development of more tailored support for people using Mounjaro® or Ozempic®.
You may be eligible to take part if you:
- Are 18-75 years old
- Are currently taking Mounjaro® or Ozempic®
- Are fluent in English and able to give informed consent
- Have access to a smartphone (to use the Google Fit app)
You will find more detailed information in the Mounjaro Ozempic Blood Glucose Study Participant Information Sheet.
Contact us
Dr Brendan M Gabriel: brendan.gabriel1@abdn.ac.uk
- GendAge Study - Help us understand how age and gender affect weight loss
-
Are you interested in helping us understand how age and gender affect weight loss?
We’re conducting a ground-breaking study to explore how sex hormones influence dieting outcomes in men and women as they age. If you are willing to help us advance women’s health research by participating in a six-week diet programme with all food provided, please contact the study research team for more information.
We are looking for healthy individuals who are:
- Aged 18-40 (men only - all spaces for women now filled) or 55-65 (men and women)
- Living with overweight or obesity (BMI 27-45 kg/m2 - we can measure this for you at the screening visit)
What is involved?
- We will assess your body composition and energy expenditure
- We will analyse your blood and fat tissue, as well as urine samples
- You will be asked to consume a specially-designed weight-loss diet with all foods prepared at the Rowett Institute by dietetic staff
- We will equip you with wearable devices to monitor your glucose and physical activity levels over the course of the study
Further information
Download the GendAge Study Participant Information Leaflet.
Contact us